Author

Brenda J. Kitchen

Observed names: B J Kitchen, B. Kitchen, BRENDA J. KITCHEN, Brenda Kitchen

Institutions: Hurley Medical Center, Michigan State University

Observed institutions: University of Southern California, National Institutes of Health, Children's Hospital of Philadelphia, Children's Hospital Los Angeles, Harvard University, Baylor College of Medicine, University of Michigan, Hurley Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Cancer Institute, Rainbow Babies & Children's Hospital, C. S. Mott Children's Hospital, National Institutes of Health Clinical Center, Michigan State University, Texas Tech University Health Sciences Center

OpenAlex ID: A5000648140

XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease

2010 · Rebecca A. Marsh, Lisa Madden, et al. · Blood · 263

Phase I Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study (ADVL0015)

2004 · Susan M. Blaney, Mark Bernstein, et al. · Journal of Clinical Oncology · 116

Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group

2011 · Judith G. Villablanca, Wendy B. London, et al. · Clinical Cancer Research · 93

A rapid flow cytometric screening test for X‐linked lymphoproliferative disease due to XIAP deficiency

2009 · Rebecca A. Marsh, Joyce Villanueva, et al. · Cytometry Part B Clinical Cytometry · 65

Cytomegalovirus infection in children with human immunodeficiency virus infection

1997 · BRENDA J. KITCHEN, HOWARD D. ENGLER, et al. · The Pediatric Infectious Disease Journal · 33

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101

2004 · P. C. Adamson, S. M. Blaney, et al. · Cancer Chemotherapy and Pharmacology · 32

Thioguanine Administered as a Continuous Intravenous Infusion to Pediatric Patients Is Metabolized to the Novel Metabolite 8-Hydroxy-Thioguanine

1999 · Brenda J. Kitchen, Asher Moser, et al. · Journal of Pharmacology and Experimental Therapeutics · 27

Cytomegalovirus Ureteritis as a Cause of Renal Failure in a Child Infected with the Human Immunodeficiency Virus

1995 · B. U. Mueller, K. MacKay, et al. · Clinical Infectious Diseases · 20

A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.

1997 · B J Kitchen, F M Balis, et al. · PubMed · 19

Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia

2006 · Brenda J. Kitchen, Laurence A. Boxer · Pediatric Blood & Cancer · 12

A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor

2013 · Ruchika Sharma, Brenda J. Kitchen, et al. · Pediatric Surgery International · 10

Parent‐to‐Child Information Disclosure in Pediatric Oncology

2026 · Rachel A. Kentor, Flora Hoodin, et al. · Pediatric Blood & Cancer · 1

Impact of case review at a multidisciplinary tumor board on the management of pediatric solid tumors

2014 · Arunachalam Thenappan, Erica Southworth, et al. · Journal of the American College of Surgeons

Works count: 13

Citation count: 691

H-index: 10

I10-index: 11